In summary, transcriptomic expression of the C7 gene was previously identified as a risk factor for AD (Song et al., 2012), whereas ZYX was known to be degraded by Aβ peptides in the neuroblastoma cell model (Lanni et al., 2013). This evidence concerns the gene ZYX and Alzheimer disease.